Physician profile
Atul Singla
NPI 1285899302
$9,587.02
in general payments reported to CMS, 2019-2025
22 companies · $2,907 in 2025
The $2,907 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,292 · 2020: $180 · 2021: $132 · 2022: $2,167 · 2023: $413 · 2024: $495 · 2025: $2,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,097 · Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,096.61 |
| Food and Beverage | $1,718.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,402.14 | 2019-2025 | Triclip, Mitraclip, Amplatzer Talisman |
| Edwards Lifesciences Corporation | $1,576.55 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $1,301.01 | 2019 | |
| Medtronic, INC. | $1,277.01 | 2022-2025 | Linq II, Corevalve Evolut R, Confida |
| Abiomed | $1,202.90 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,202.01 | 2019-2023 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $173.79 | 2022-2025 | |
| Shockwave Medical, INC | $110.57 | 2021 | |
| Inari Medical, INC. | $60.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $30.27 | 2024 | Collagenase Santyl |
| Pfizer INC. | $28.87 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.27 | 2025 | |
| Siemens Medical Solutions USA, INC. | $26.10 | 2022 | |
| Philips North America LLC | $25.76 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.75 | 2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $21.40 | 2025 | |
| Chiesi USA, INC. | $19.37 | 2023 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $18.84 | 2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $17.64 | 2025 | Amvuttra |
| Medtronic USA, INC. | $16.24 | 2019 | |
| Novo Nordisk INC | $13.70 | 2023 | |
| Osprey Medical INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.